切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2014, Vol. 01 ›› Issue (01) : 34 -38. doi: 10.3877/cma.j.issn.2095-8757.2014.01.010

所属专题: 总编推荐 文献

临床研究

经颈内静脉肝内门腔静脉分流术治疗老年肝硬化门静脉高压症疗效分析
吴正忠1, 杨维竹1, 江娜1, 郑曲彬1, 黄兢姚1, 黄宁1   
  1. 1. 350001 福州,福建医科大学附属协和医院介入科
  • 收稿日期:2014-11-17 出版日期:2014-11-30

Cinical analysis of treatment for senile cirrhosis and portal hypertension after transjugular intrahepatic portosystemic stent shunt

Zhengzhong Wu1, Weizhu Yang1, Na Jiang1, Qubin Zheng1, Jingyao Huang1, Ning HUANG1   

  1. 1. Department of Interventional Radiology, Union Hospital, Fujian Medical Univercity, Fuzhou 350001, China
  • Received:2014-11-17 Published:2014-11-30
引用本文:

吴正忠, 杨维竹, 江娜, 郑曲彬, 黄兢姚, 黄宁. 经颈内静脉肝内门腔静脉分流术治疗老年肝硬化门静脉高压症疗效分析[J/OL]. 中华老年病研究电子杂志, 2014, 01(01): 34-38.

Zhengzhong Wu, Weizhu Yang, Na Jiang, Qubin Zheng, Jingyao Huang, Ning HUANG. Cinical analysis of treatment for senile cirrhosis and portal hypertension after transjugular intrahepatic portosystemic stent shunt[J/OL]. Chinese Journal of Geriatrics Research(Electronic Edition), 2014, 01(01): 34-38.

目的

探讨经颈内静脉肝内门腔静脉分流术(TIPSS)治疗老年肝硬化门静脉高压症的疗效。

方法

2008年1月至2014年6月福建医科大学附属协和医院选取老年肝硬化门静脉高压症患者119例,均经内科治疗无效后择期行TIPSS治疗。术后随访24个月,观察记录患者手术前后的门静脉压力,以及术后3,6,12,24个月再出血发生情况、腹水治疗情况、分流道狭窄发生情况。手术前后门静脉压力比较采用配对t检验,发生率的比较采用χ2检验。

结果

所有患者均成功置入支架建立分流道,其中75例采用Fluency覆膜支架,44例采用金属裸支架。患者TIPSS前后门静脉压力分别为(35.00±6.55)cmH2O及(20.92±6.63) cmH2O,差异有统计学意义(t=13.43,P<0.01)。术后3,6,12,24个月,36例顽固性腹水患者TIPSS后腹水完全缓解及部分缓解率分别为82.35%,84.85%,85.19%,76.00%;91例食管胃底静脉曲张破裂出血患者再出血发生率分别为5.49%,12.94%,22.72%,33.33%;119例患者分流道狭窄发生率分别为4.27%,10.00%,14.28%,24.19%。随访24个月,裸支架组狭窄率为47.73%,覆膜支架组狭窄率为17.33%,差异有统计学意义(χ2=12.55,P<0.01)。

结论

TIPSS具有疗效好、创伤小、操作时间短、并发症少、肝功能损害轻等优点,是老年肝硬化门静脉高压症的有效治疗手段;术中应用覆膜支架可能会明显降低支架狭窄发生率。

Objective

To evaluate the effect of transjuaular intrahepatic portosystemic stent shunt (TIPSS) in the treatment of senile cirrhosis and portal hypertension.

Methods

A retrospective analysis was reviewed on the 119 elder patients with senile cirrhosis and esophageal varices bleeding and refractory ascites. All of them underwent TIPSS after medical treatment fails. They were strictly followed up for 2 years and their clinical data were analysed. Color doppler imaging and shunt angiography were used to follow up patients to analyze the cases and type of stenosis.

Results

All patients were successfully implanted with stents (75 cases with the fluency stents, 44 cases with bare-metal stents)to establish shunt. Portal venous pressure from before TIPSS (35.00±6.55) cmH2O to after TIPSS (20.92±6.63) cmH2O(t=13.43, P<0.01). There is a significant difference. TIPSS after 3 months, 6 months, 12 months and 24 months ascites complete or partial remission rates were 82.35%, 84.85%, 85.19% and 76.00%, rebleeding rates were 5.49%, 12.94%, 22.72% and 33.33%, incidence of shunt stenosis were 4.27%, 10.00%, 14.28% and 24.19%. After 2-year follow-up, the bare stent group had 47.73% stenosis; the covered stent group had 17.33% (χ2=12.55, P<0.01). The difference between two groups was statistically significant.

Conclusion

TIPSS is available and satisfactory in the treatment of senile cirrhosis and portal hypertension, which has high efficacy. TIPSS is less invasive, takes shorter operation tim, causes fewer complications. Stenosis rate can be significantly decreased by the application of covered stent in TIPSS.

表1 36例乙肝肝硬化合并门静脉高压腹水患者TIPSS治疗后不同时期腹水缓解情况(例)
图1 患者男,70岁,经颈静脉肝内门腔静脉分流术后6个月复查,经支架直接门静脉造影显示支架肝静脉端狭窄,血流不通畅,近乎"盖帽"
[1]
Qin JP, Jiang MD, Tang W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center[J]. World J Gastroenterol,2013,19(44):8085-8092.
[2]
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis[J]. N Engl J Med,2010,362(9):823-832.
[3]
Qi X, Liu L, Bai M, et al. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis[J]. J Gastroenterol Hepatol,2014,29(4):688-696.
[4]
García-Pagán JC, Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. Ann Intern Med,2010,16,153(10):JC5-13.
[5]
Deipolyi AR, Kalva SP, Oklu R, et al. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices[J]. AJR Am J Roentgenol,2014,203(3):668-673.
[6]
Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update[J]. Gut,2010,59(7):988-1000.
[7]
Narahara Y, Kanazawa H, Fukuda T, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial[J]. J Gastroenterol,2011,46(1):78-85.
[8]
Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009.American Association for the study of liver diseases[J]. Hepatology,2010,51(1):306.
[9]
贺平,李成杰,张紫寅,等.不同直径PTFE覆膜支架在门脉高压TIPSS术中的应用效果[J].海南医学,2013,24(19):2828-2831.
[10]
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest,2008,133(6 Suppl):454S-545S.
[11]
Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study[J]. Liver Int,2007,27(6):742-747.
[12]
Jung HS, Kalva SP, Greenfield AJ, et al. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts[J]. J Vasc Interv Radiol,2009,20(2):180-185.
[13]
鲍应军,顾俊鹏,纪卫政,等.PTFE覆膜支架与裸支架在TIPSS治疗门静脉高压症中的疗效比较[J].中国普通外科杂志,2014,23(1):83-86.
[14]
褚建国,孙晓丽,黄鹤,等.经皮经肝门腔静脉分流术[J].介人放射学杂志,2005,27(4):367-371.
[1] 陈晓玲, 钟永洌, 刘巧梨, 李娜, 张志奇, 廖威明, 黄桂武. 超高龄髋膝关节术后谵妄及心血管并发症风险预测[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 575-584.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[4] 李佳伟, 庞建智, 闫鹏宇, 卫阳兵, 杨晓峰. 术中输尿管识别技术研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 520-524.
[5] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[6] 宋俊锋, 张珍珍. 单侧初发性腹股沟斜疝老年患者经腹腹膜前疝修补术中残余疝囊腹直肌下缘固定效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 670-674.
[7] 张晋伟, 董永红, 王家璇. 基于GBD2021 数据库对中国与全球老年人疝疾病负担和健康不平等的分析比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 708-716.
[8] 邵世锋, 肖钦, 沈方龙, 张迅, 郝志鹏, 伍正彬, 谢晓娟, 王耀丽. 老年胸主动脉钝性伤的重症救治分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 762-767.
[9] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[10] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[11] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[12] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[14] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[15] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?